medroxyprogesterone has been researched along with Cancer of Endometrium in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (36.11) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 8 (22.22) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Chen, J; Huang, H; Pan, L; Wang, J; Xiang, Y; Yang, J | 1 |
| Ding, F; Jiang, J; Kong, D; Li, W; Liu, Z; Ma, X; Qiu, C | 1 |
| Bae, HS; Hwang, JY; Jung, YW; Kim, DH; Kim, MK; Kim, ML; Seong, SJ; Shin, E; Yun, BS | 1 |
| Chae, SH; Kang, SB; Kim, SN; Lee, JY; Lee, SJ; Shim, SH | 1 |
| Liu, H; Wang, H; Wang, J; Wang, Y; Zhou, R | 1 |
| Cao, DY; Cheng, NH; Deng, CY; He, FF; Huang, HF; Shen, K; Sun, ZY; Yang, JX; Yu, M; Yu, Q | 1 |
| Meng, Q; Sun, X; Wang, J; Wang, Y | 1 |
| Fadare, O; Yamani, F | 1 |
| Franco, EL; Gotlieb, WH; Greenwald, ZR; Huang, LN; Wissing, MD | 1 |
| Jaeger, R; Moe, BT; Orbo, A; Sager, G; Vereide, AB | 1 |
| Ai, Z; Lu, L; Teng, Y; Tong, J; Wang, J; Wang, Y | 1 |
| Chao, V; Dreher, E; Mueller, MD; Pritts, EA; Taylor, RN; Vigne, JL | 1 |
| Ito, K; Konno, R; Moriya, T; Okamura, K; Sasano, H; Sato, S; Suzuki, T; Utsunomiya, H; Yaegashi, N | 1 |
| Bäckström, T; Boman, K; Cajander, S; Dahmoun, M | 1 |
| Cornuz, J; Lamy, O; Wirthner, D | 1 |
| Arai, T; Jobo, T; Kawaguchi, M; Kuramoto, H | 1 |
| Kaino, T; Sager, G; Vereide, AB; Ørbo, A | 1 |
| Chang, WH; Chen, CH; Yu, MH | 1 |
| Aoki, Y; Fujita, K; Tanaka, K; Yahata, T | 1 |
| Wang, J; Wang, Z; Wei, L | 1 |
| Amant, F; Berteloot, P; De Knijf, A; Leunen, K; Moerman, P; Neven, P; Van Calster, B; Van Huffel, S; Vergote, I | 1 |
| Dalrymple, JC; Russell, P | 1 |
| Castelo-Branco, C; Durán, M; Fortuny, A; Gratacós, E; Puerto, B; Torné, A; Vanrell, JA | 1 |
| Kedzia, H; Warenik-Szymankiewicz, A; Wolna, M | 1 |
| Jick, SS | 1 |
| Arduino, S; Bellino, R; Febo, G; Lanza, A; Leo, L; Tessarolo, M; Wierdis, T | 1 |
| Crespo, C; García-López, J; González-Martín, A; Lastra, E; Moyano, A | 1 |
| Imai, M; Jobo, T; Kawaguchi, M; Kenmochi, M; Kuramoto, H | 1 |
| Fujiwara, M; Hayakawa, J; Inoue, M; Koike, K; Kyo, S; Maida, Y; Ohmichi, M; Takakura, M; Tanaka, M; Wang, Z; Yatabe, N | 1 |
| Fukushima, A; Izutsu, T; Kagabu, T; Nishiya, I | 1 |
| Ishizaki, T; Itoh, R; Okada, H; Yamamoto, T | 1 |
| Gong, Y; Murphy, LC; Murphy, LJ | 1 |
| Clarke, CL; Mortel, R; Satyaswaroop, PG; Zaino, RJ | 1 |
| Pike, MC; Shoupe, D; Spicer, DV | 1 |
| Guillebaud, J; Szareswki, A | 1 |
| Fung, MF; Heywood, M; Krepart, GV; Lotocki, RJ | 1 |
4 review(s) available for medroxyprogesterone and Cancer of Endometrium
| Article | Year |
|---|---|
[Preventing of postmenopausal osteoporosis by hormone replacement therapy? Is the risk acceptable?].
Topics: Age Factors; Aged; Alzheimer Disease; Breast Neoplasms; Cardiovascular Diseases; Climacteric; Colonic Neoplasms; Endometrial Neoplasms; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hysterectomy; Medroxyprogesterone; Meta-Analysis as Topic; Middle Aged; Multivariate Analysis; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Placebos; Prognosis; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Risk; Risk Factors; Socioeconomic Factors; Time Factors | 2004 |
[Borderline lesions in the endometrium].
Topics: Cell Transformation, Neoplastic; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Estrogens; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Progesterone Congeners | 2004 |
GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer.
Topics: Bone and Bones; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Lipid Metabolism; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Ovary; Risk Factors | 1991 |
Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Survival Rate | 1991 |
2 trial(s) available for medroxyprogesterone and Cancer of Endometrium
| Article | Year |
|---|---|
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Topics: Administration, Oral; Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biopsy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Progestins; Proto-Oncogene Proteins c-bcl-2 | 2005 |
Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Biopsy; Climacteric; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Monitoring, Physiologic; Ultrasonography | 1994 |
30 other study(ies) available for medroxyprogesterone and Cancer of Endometrium
| Article | Year |
|---|---|
Low-grade endometrial stromal sarcoma with intracaval or intracardiac extension: a retrospective study of eight cases.
Topics: Adult; Endometrial Neoplasms; Female; Humans; Letrozole; Medroxyprogesterone; Retrospective Studies; Sarcoma, Endometrial Stromal | 2022 |
CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Endometrium; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MAP Kinase Signaling System; Medroxyprogesterone; Mice, Inbred BALB C; Mice, Nude; Receptor, Cannabinoid, CB1; Up-Regulation; Uterine Diseases | 2021 |
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.
Topics: Administration, Oral; Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2017 |
Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies; Treatment Outcome | 2019 |
Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Rate; Retrospective Studies; Treatment Outcome | 2019 |
[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Infertility, Female; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
[Mechanism of thioridazine plus medroxyprogesterone in the treatment of endometrial cancer].
Topics: Apoptosis; Apoptosis Regulatory Proteins; Endometrial Neoplasms; Female; Flow Cytometry; Humans; Medroxyprogesterone; Phosphatidylinositol 3-Kinases; Real-Time Polymerase Chain Reaction; Signal Transduction; Thioridazine | 2015 |
Arias-Stella Reaction in Progestin-Treated Endometrioid Adenocarcinoma: A Potential Diagnostic Pitfall.
Topics: Carcinoma, Endometrioid; Endometrial Neoplasms; Endometrium; Female; Humans; Medroxyprogesterone; Middle Aged; Progestins | 2016 |
Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cause of Death; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Kaplan-Meier Estimate; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Propensity Score; Proportional Hazards Models; SEER Program; Time Factors; United States | 2017 |
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Synergism; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Medroxyprogesterone; Mifepristone; Progesterone; Progestins; Receptors, Progesterone | 2009 |
Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway.
Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Endometrial Neoplasms; ErbB Receptors; Female; Humans; MAP Kinase Signaling System; Medroxyprogesterone; Progesterone; Progestins; Signal Transduction; Transfection; Up-Regulation | 2010 |
Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Medroxyprogesterone; Mifepristone; Promegestone; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Biomarkers; Endometrial Neoplasms; Estradiol Dehydrogenases; Female; Follow-Up Studies; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone; Progesterone Congeners; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome | 2003 |
Intratumoral effects of medroxy-progesterone on proliferation, apoptosis, and sex steroid receptors in endometrioid endometrial adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Apoptosis; Cell Division; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Suppressor Protein p53 | 2004 |
Conservative therapy of stage I endometrial adenocarcinoma and atypical endometrial hyperplasia for the preservation of fertility.
Topics: Adenocarcinoma; Adult; Contraceptives, Oral, Synthetic; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Infertility, Female; Medroxyprogesterone; Treatment Outcome | 2006 |
Long-term conservative therapy for endometrial adenocarcinoma in young women.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Hysterectomy; Medroxyprogesterone; Pregnancy; Treatment Outcome | 2006 |
Analysis of adjuvant endocrine therapy on the prognosis of endometrial carcinoma confined to the uterus.
Topics: Carcinoma; Case-Control Studies; Chemotherapy, Adjuvant; China; Contraceptives, Oral, Synthetic; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Receptors, Estrogen; Retrospective Studies | 2007 |
Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma.
Topics: Adolescent; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Medroxyprogesterone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Sarcoma, Endometrial Stromal; Treatment Outcome | 2007 |
Primary endometrial squamous cell carcinoma with long-term survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone; Middle Aged; Ovariectomy; Retrospective Studies; Survival Analysis; Vinblastine | 1993 |
[Conservative treatment of two young women with cancer and precancerous lesions of the endometrium].
Topics: Adult; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Precancerous Conditions; Treatment Outcome | 1994 |
Combined estrogen and progesterone use and endometrial cancer.
Topics: Confidence Intervals; Endometrial Neoplasms; Estradiol Congeners; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Medroxyprogesterone; Middle Aged; Risk Factors; Washington | 1993 |
Endometrial carcinoma in women 45 years of age or younger.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Adult; Age Distribution; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Progesterone Congeners; Prognosis; Radiotherapy, Adjuvant; Survival Rate | 1996 |
Metastatic endometrial cancer in lung and liver: complete and prolonged response to hormonal therapy with progestins.
Topics: Carcinoma; Endometrial Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Tomography, X-Ray Computed | 1999 |
Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases.
Topics: Adenocarcinoma; Adult; Drug Administration Schedule; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Pregnancy; Progesterone Congeners; Treatment Outcome | 2000 |
Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway.
Topics: Breast Neoplasms; DNA-Binding Proteins; Drug Interactions; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Medroxyprogesterone; Progesterone; Progesterone Congeners; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Telomerase; Transcription, Genetic; Tumor Cells, Cultured | 2000 |
[Analysis of DNA synthetic cells in endometrial carcinoma cases treated with progestogen].
Topics: Adenocarcinoma; DNA, Neoplasm; Endometrial Neoplasms; Female; Flow Cytometry; Humans; Medroxyprogesterone; Prognosis; S Phase; Tumor Cells, Cultured | 1992 |
[Estimation of medroxyprogesterone acetate against a human endometrial tumor constituted from the established Ishikawa cancer cells by a subrenal capsule assay].
Topics: Animals; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Subrenal Capsule Assay; Tumor Cells, Cultured | 1992 |
Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Division; Cell Line; Endometrial Neoplasms; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Oligonucleotides, Antisense; Steroids; Tamoxifen; Transforming Growth Factor alpha; Transforming Growth Factor beta | 1992 |
Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor.
Topics: Animals; Blotting, Western; Carcinoma; Cell Division; Down-Regulation; Drug Resistance; Endometrial Neoplasms; Female; Male; Medroxyprogesterone; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Progesterone; Tamoxifen | 1992 |
Safety of DMPA.
Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk Factors | 1991 |